Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation

CONCLUSIONS: CD26 is expressed in the IIM skeletal muscle and may represent a target of molecular intervention for patients with treatment-refractory myositis.PMID:34796850

Source: Clinical and Experimental Rheumatology - November 19, 2021 Category: Rheumatology Authors: Rebecca De Lorenzo Antonella Monno Clara Sciorati Isabella Lorenzetti Silvia Cavalli Francesco Bonomi Stefano Carlo Previtali Patrizia Rovere-Querini Source Type: research